NCT02531191View on ClinicalTrials.gov

Bioequivalence Evaluation of a New and Current Tablet of ASP015K

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 21, 2015

Primary Completion Date

July 15, 2015

Study Completion Date

July 15, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

peficitinib

oral

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY